A common pattern of somatic mutations in t‐MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer. Issue 11 (8th September 2022) - Chiusolo, Patrizia; Marchetti, Claudia; Rossi, Monica; Minnella, Gessica; Salutari, Vanda; Distefano, Mariagrazia; Giammarco, Sabrina; Metafuni, Elisabetta; Minucci, Angelo; Frioni, Filippo; Gasbarrino, Cristiana; Colangelo, Maria; et al.